STOCK TITAN
  1. Home
  2. ABPO

ABPRO HLDGS (ABPO) Stock Price, News & Analysis

ABPO OTC Link

Company Description

ABPRO HLDGS (OTC Link: ABPO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.4M.

ABPO has declined 12.5% over the past month. Shares last traded at $0.2293.

For FY2025, ABPRO HLDGS reported net income of -$2.9M and diluted earnings per share of -$1.30.

This page collects what Stock Titan holds for ABPO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$0.2293
+4.23%
+0.01
Last updated: September 3, 2026 at 15:26
-12.5%
Performance 1 month
$1.4M
Market Cap
5.9M
Shares outstanding

ABPRO HLDGS (ABPO) stock last closed at $0.2293. Over the past month, the stock has lost 12.5%. At a market capitalization of $1.4M, ABPO is classified as a micro-cap stock with approximately 5.9M shares outstanding.

See what a $1,000 investment in ABPO would be worth today

Latest News

View All

No recent news available for ABPO.

SEC Filings

View All

[8-K] Abpro Holdings (OTC Pink: ABPO) chair steps down as consulting deal ends with a $50,000 payout.

[8-K] Ex-UBS financier to lead Abpro (OTC: ABPO) as unpaid interim CEO

[10-Q] Abpro Holdings (ABPO) delisted to OTC Pink, flags going-concern risks in Q2

[SCHEDULE 13G/A] Abpro Holdings (ABPO): Goldman Sachs reports 180,690-share, 3.0% beneficial stake

[8-K] Abpro Holdings (ABP) Nasdaq delisting reaffirmed, trading shifts to OTC Pink

ABPRO HLDGS has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-Q, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on August 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ABPO SEC filings →

Financial Highlights

View Full Financials

net income was -$2.9M. Diluted earnings per share stood at -$1.30. With a current ratio of 0.10, short-term liquidity bears monitoring.

-$2.9M
Net Income (FY2025)
-$1.30
Diluted EPS (FY2025)
0.10
Current Ratio
—
Revenue (FY2025)
—
Operating Cash Flow
—
Net Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Short interest in ABPRO HLDGS (ABPO) currently stands at 16.5 thousand shares, up 26.8% from the previous reporting period, representing 0.3% of the float. Since February 2026, short interest has decreased by 82.1%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for ABPRO HLDGS (ABPO) currently stands at 1.0 days, down 43.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.7 days.

ABPO Company Profile & Sector Positioning

ABPRO HLDGS (ABPO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.

Frequently Asked Questions

What is the current stock price of ABPRO HLDGS (ABPO)?

The current stock price of ABPRO HLDGS (ABPO) is $0.2293 as of September 3, 2026.

What is the market cap of ABPRO HLDGS (ABPO)?

The market cap of ABPRO HLDGS (ABPO) is approximately 1.4M. Learn more about what market capitalization means .

What is the net income of ABPRO HLDGS (ABPO)?

The FY2025 net income of ABPRO HLDGS (ABPO) is -$2.9M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of ABPRO HLDGS (ABPO)?

The diluted earnings per share (EPS) of ABPRO HLDGS (ABPO) is -$1.30 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the current ratio of ABPRO HLDGS (ABPO)?

The current ratio of ABPRO HLDGS (ABPO) is 0.10, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.